Obstructive sleep apnea (OSA) is associated with serious comorbid illnesses and diminished quality of life. At this time, continuous positive airway pressure (CPAP) therapy is the treatment of choice. However, only half of those individuals who accept CPAP are still using it at the end of one year. Furthermore, efficacy for improving self-reported sleepiness appears to be greater for patients with severe sleep apnea and severe sleepiness than other patient groups. Some patients, notwithstanding optimized therapy and therapeutic adherence continue experiencing excessive daytime somnolence. Consequently, other treatment modalities have developed, including oral appliances, surgery and pharmacotherapy. It is widely believed, albeit not empirically demonstrated, that an effective medication to treat OSA would elicit better acceptance and adherence than having to use a machine for many hours on a nightly basis. Nonetheless, paucity of data (i.e. lack of large-scale randomized controlled trials), variability of perceived and actual benefits, and adverse side-effects of the drugs thus far tested have prevented the use of pharmacotherapy until now. In this paper we review the outcome data from published trials designed to evaluate efficacy and safety of various medications proposed for treating obstructive sleep apnea.
Arnulf, I., Homeyer, P., Garma, L., Whitelaw, W.A. and Derenne, J.P. (1997) Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. Respiration64(2): 159-161.
2.
Atkinson, R.L., Suratt, P.M., Wilhoit, S.C. and Recant, L. (1985) Naloxone improves sleep apnea in obese humans. Int J Obes9(4): 233-239.
3.
Berry, R.B., Koch, G.L. and Hayward, L.F. (2005) Low-dose mirtazapine increases genioglossus activity in the anesthetized rat. Sleep28(1): 78-84.
4.
Berry, R.B., Yamaura, E.M., Gill, K. and Reist, C. (1999) Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea. Sleep22(8): 1087-1092.
5.
Black, J.E. and Hirshkowitz, M. (2005) Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep28(4): 464-471.
6.
Block, A.J., Wynne, J.W., Boysen, P.G., Lindsey, S., Martin, C. and Cantor, B. (1981) Menopause, medroxyprogesterone and breathing during sleep. Am J Med70(3): 506-510.
7.
Bradley, T.D. and Floras, J.S. (2003) Sleep apnea and heart failure: Part II: central sleep apnea. Circulation107(13): 1822-1826.
8.
Braver, H.M. and Block, A.J. (1994) Effect of nasal spray, positional therapy, and the combination thereof in the asymptomatic snorer. Sleep17(6): 516-521.
9.
Brownell, L.G., West, P., Sweatman, P., Acres, J.C. and Kryger, M.H. (1982) Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med307(17): 1037-1042.
10.
Carley, D.W., Olopade, C., Ruigt, G.S. and Radulovacki, M. (2007) Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep30(1): 35-41.
11.
Chauncey, J.B. and Aldrich, M.S. (1990) Preliminary findings in the treatment of obstructive sleep apnea with transtracheal oxygen. Sleep13(2): 167-174.
12.
Cistulli, P.A., Barnes, D.J., Grunstein, R.R. and Sullivan, C.E. (1994) Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax49(7): 699-702.
13.
Cook, W.R., Benich, J.J. and Wooten, S.A. (1989) Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest96(2): 262-266.
14.
Davila, D.G., Hurt, R.D., Offord, K.P., Harris, C.D. and Shepard, Jr. J.W. (1994) Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med150(2): 469-474.
15.
Decary, A., Rouleau, I. and Montplaisir, J. (2000) Cognitive deficits associated with sleep apnea syndrome: a proposed neuropsychological test battery. Sleep23(3): 369-381.
16.
Eli Lilly. (2007) Prozacâ (fluoxetine) capsules, oral solution, and delayed-release capsules prescribing information. Indianapolis : Eli Lilly and Company.
17.
Engleman, H.M., Kingshott, R.N., Martin, S.E. and Douglas, N.J. (2000) Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep23(Suppl. 4): S102-S108.
18.
Espinoza, H., Antic, R., Thornton, A.T. and McEvoy, R.D. (1987) The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis136(1): 80-84.
19.
Farney, R.J., Walker, J.M., Elmer, J.C., Viscomi, V.A. and Ord, R.J. (1992) Transtracheal oxygen, nasal CPAP and nasal oxygen in five patients with obstructive sleep apnea. Chest101(5): 1228-1235.
20.
Findley, L.J., Weiss, J.W. and Jabour, E.R. (1991) Drivers with untreated sleep apnea. A cause of death and serious injury. Arch Intern Med151(7): 1451-1452.
21.
Food and Drug Administration (2008) Serious Skin and Hypersensitivity Reactions with Provigil.
22.
Available at: <http://www.accessdata.fda.gov/psn/transcript.cfm?show=71> ;
23.
Gilman, S., Chervin, R.D., Koeppe, R.A., Consens, F.B., Little, R., An, H. et al. (2003) Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA. Neurology61(1): 35-39.
24.
Gothe, B., Strohl, K.P., Levin, S. and Cherniack, N.S. (1985) Nicotine: a different approach to treatment of obstructive sleep apnea. Chest87(1): 11-17.
25.
Grunstein, R.R., Ho, K.K. and Sullivan, C.E. (1994) Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Ann Intern Med121(7): 478-483.
26.
Guilleminault, C. and Hayes, B. (1983) Naloxone, theophylline, bromocriptine, and obstructive sleep apnea. Negative results. Bull Eur Physiopathol Respir19(6): 632-634.
27.
Hanzel, D.A., Proia, N.G. and Hudgel, D.W. (1991) Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest100(2): 416-421.
28.
Haxhiu, M.A., van Lunteren, E., Van de Graaff, W.B., Strohl, K.P., Bruce, E.N., Mitra, J. et al. (1984) Action of nicotine on the respiratory activity of the diaphragm and genioglossus muscles and the nerves that innervate them. Respir Physiol57(2): 153-169.
29.
Hedner, J., Kraiczi, H., Peker, Y. and Murphy, P. (2003) Reduction of sleep-disordered breathing after physostigmine . Am J Respir Crit Care Med168(10): 1246-1251.
30.
Hein, H., Behnke, G., Jorres, R.A. and Magnussen, H. (2000) The therapeutic effect of theophylline in mild obstructive sleep apnea/hypopnea syndrome: results of repeated measurements with portable recording devices at home. Eur J Med Res5(9): 391-399.
31.
Heitmann, J., Cassel, W., Grote, L., Bickel, U., Hartlaub, U., Penzel, T. et al. (1999) Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea? Clin Pharmacol Ther65(3): 328-335.
32.
Hirshkowitz, M. and Black, J. (2007) Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study. CNS Drugs21(5): 407-416.
33.
Ip, M.S., Tan, K.C., Peh, W.C. and Lam, K.S. (2001) Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity . Clin Endocrinol (Oxf) 55(4): 477-483.
34.
Issa, F.G. (1992) Effect of clonidine in obstructive sleep apnea . Am Rev Respir Dis145(2 Pt 1): 435-439.
35.
Javaheri, S. (1996) Central sleep apnea-hypopnea syndrome in heart failure: prevalence, impact, and treatment. Sleep19(Suppl. 10): S229-S231.
36.
Jokic, R., Klimaszewski, A., Mink, J. and Fitzpatrick, M.F. (1998) Surface tension forces in sleep apnea: the role of a soft tissue lubricant: a randomized double-blind, placebo-controlled trial. Am J Respir Crit Care Med157(5 Pt 1): 1522-1525.
37.
Keefe, D.L., Watson, R. and Naftolin, F. (1999) Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause6(3): 196-200.
38.
Kiely, J.L., Nolan, P. and McNicholas, W.T. (2004) Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis . Thorax59(1): 50-55.
39.
Kingshott, R.N., Vennelle, M., Coleman, E.L., Engleman, H.M., Mackay, T.W. and Douglas, N.J. (2001) Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med163(4): 918-923.
40.
Kraiczi, H., Hedner, J., Dahlof, P., Ejnell, H. and Carlson, J. (1999) Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep22(1): 61-67.
41.
Landsberg, R., Friedman, M. and Ascher-Landsberg, J. (2001) Treatment of hypoxemia in obstructive sleep apnea. Am J Rhinol15(5): 311-313.
42.
Liu, P.Y., Yee, B., Wishart, S.M., Jimenez, M., Jung, D.G., Grunstein, R.R. et al. (2003) The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab88(8): 3605-3613.
43.
Manber, R., Kuo, T.F., Cataldo, N. and Colrain, I.M. (2003) The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep26(2): 163-168.
44.
Mansfield, D.R., Gollogly, N.C., Kaye, D.M., Richardson, M., Bergin, P. and Naughton, M.T. (2004) Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med169(3): 361-366.
45.
Marshall, N.S., Yee, B.J., Desai, A.V., Buchanan, P.R., Wong, K.K., Crompton, R. et al. (2008) Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. Sleep31(6): 824-831.
46.
Mulloy, E. and McNicholas, W.T. (1992) Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest101(3): 753-757.
47.
Nieto, F.J., Young, T.B., Lind, B.K., Shahar, E., Samet, J.M., Redline, S. et al. (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA283(14): 1829-1836.
48.
O'Halloran, K.D., Herman, J.K. and Bisgard, G.E. (2000) Clonidine induces upper airway closure in awake goats. Respir Physiol123(3): 165-176.
Orth, M.M., Grootoonk, S., Duchna, H.W., de Zeeuw, J., Walther, J.W., Bauer, T.T. et al. (2005) Short-term effects of oral theophylline in addition to CPAP in mild to moderate OSAS. Respir Med99(4): 471-476.
51.
Pack, A.I., Black, J.E., Schwartz, J.R. and Matheson, J.K. (2001) Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med164(9): 1675-1681.
52.
Patel, S.R., White, D.P., Malhotra, A., Stanchina, M.L. and Ayas, N.T. (2003) Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med163(5): 565-571.
53.
Phillips, B.A., Schmitt, F.A., Berry, D.T., Lamb, D.G., Amin, M. and Cook, Y.R. (1990) Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. Chest98(2): 325-330.
54.
Pickett, C.K., Regensteiner, J.G., Woodard, W.D., Hagerman, D.D., Weil, J.V. and Moore, L.G. (1989) Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol66(4): 1656-1661.
55.
Polo-Kantola, P., Rauhala, E., Helenius, H., Erkkola, R., Irjala, K. and Polo, O. (2003) Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol102(1): 68-75.
56.
Quan, S.F., Howard, B.V., Iber, C., Kiley, J.P., Nieto, F.J., O'Connor, G.T. et al. (1997) The Sleep Heart Health Study: design, rationale, and methods. Sleep20(12): 1077-1085.
57.
Rajagopal, K.R., Abbrecht, P.H., Derderian, S.S., Pickett, C., Hofeldt, F., Tellis, C.J. et al. (1984) Obstructive sleep apnea in hypothyroidism . Ann Intern Med101(4): 491-494.
58.
Saletu, B., Oberndorfer, S., Anderer, P., Gruber, G., Divos, H., Lachner, A. et al. (1999) Efficiency of continuous positive airway pressure versus theophylline therapy in sleep apnea: comparative sleep laboratory studies on objective and subjective sleep and awakening quality. Neuropsychobiology39(3): 151-159.
59.
Saletu-Zyhlarz, G., Anderer, P., Gruber, G., Mandl, M., Gruber, D., Metka, M. et al. (2003) Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogenprogestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res12(3): 239-254.
60.
Sharp, J.T., Druz, W.S., D'Souza, V. and Diamond, E. (1985) Effect of metabolic acidosis upon sleep apnea. Chest87(5): 619-624.
61.
Skjodt, N.M., Atkar, R. and Easton, P.A. (1999) Screening for hypothyroidism in sleep apnea. Am J Respir Crit Care Med160(2): 732-735.
62.
Smith, I., Lasserson, T.J. and Wright, J. (2006) Drug therapy for obstructive sleep apnoea in adults . Cochrane Database Syst Rev: CD003002.
63.
Smith, P.L., Haponik, E.F., Allen, R.P. and Bleecker, E.R. (1983) The effects of protriptyline in sleep-disordered breathing. Am Rev Respir Dis127(1): 8-13.
64.
Stewart, D.A., Grunstein, R.R., Berthon-Jones, M., Handelsman, D.J. and Sullivan, C.E. (1992) Androgen blockade does not affect sleep-disordered breathing or chemosensitivity in men with obstructive sleep apnea. Am Rev Respir Dis146(6): 1389-1393.
65.
Suratt, P.M., Wilhoit, S.C., Brown, E.D. and Findley, L.J. (1986) Effect of doxapram on obstructive sleep apnea. Bull Eur Physiopathol Respir22(2): 127-131.
66.
Tkacova, R., Rankin, F., Fitzgerald, F.S., Floras, J.S. and Bradley, T.D. (1998) Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation98(21): 2269-2275.
67.
Tojima, H., Kunitomo, F., Kimura, H., Tatsumi, K., Kuriyama, T. and Honda, Y. (1998) Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax43(2): 113-119.
68.
Zevin, S., Swed, E. and Cahan, C. (2003) Clinical Effects of Locally Delivered Nicotine in Obstructive Sleep Apnea Syndrome. Am J Ther10: 170-175.
69.
Veasey, S.C., Panckeri, K.A., Hoffman, E.A., Pack, A.I. and Hendricks, J.C. (1996) The effects of serotonin antagonists in an animal model of sleep-disordered breathing. Am J Respir Crit Care Med153(2): 776-786.
70.
Veasey, S.C., Poli, F., Kare, P., Pack, A.I. and Hendricks, J.C. (1999) The effects of trazodone with l-tryptophan on sleep-disordered breathing in the English bulldog. Am J Respir Crit Care Med1999; 160(5): 1659-1667.
71.
Weaver, T.E. (2008) Adherence to continuous positive airway pressure treatment and functional status in adult obstructive sleep apnea. In Pack, A.I. (ed.) Sleep Apnea. Pathogenesis, Diagnosis, and Treatment. New York: Marcel Dekker, 523-554.
72.
Weaver, T.E., Laizner, A.M., Evans, L.K., Maislin, G., Chugh, D.K., Lyon, K. et al. (1997) An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep20(10): 835-843.
73.
Weiss, J.W., Launois, S.H., Anand, A. and Garpestad, E. (1999) Cardiovascular morbidity in obstructive sleep apnea . Prog Cardiovasc Dis41(5): 367-376.
74.
Whyte, K.F., Gould, G.A., Airlie, M.A., Shapiro, C.M. and Douglas, N.J. (1988) Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep11(5): 463-472.
75.
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S. and Badr, S. (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med328(17): 1230-1235.
